Literature DB >> 34210081

Molecular Biology of the WWOX Gene That Spans Chromosomal Fragile Site FRA16D.

Cheng Shoou Lee1, Amanda Choo1, Sonia Dayan1, Robert I Richards1, Louise V O'Keefe1.   

Abstract

It is now more than 20 years since the FRA16D common chromosomal fragile site was characterised and the WWOX gene spanning this site was identified. In this time, much information has been discovered about its contribution to disease; however, the normal biological role of WWOX is not yet clear. Experiments leading to the identification of the WWOX gene are recounted, revealing enigmatic relationships between the fragile site, its gene and the encoded protein. We also highlight research mainly using the genetically tractable model organism Drosophila melanogaster that has shed light on the integral role of WWOX in metabolism. In addition to this role, there are some particularly outstanding questions that remain regarding WWOX, its gene and its chromosomal location. This review, therefore, also aims to highlight two unanswered questions. Firstly, what is the biological relationship between the WWOX gene and the FRA16D common chromosomal fragile site that is located within one of its very large introns? Secondly, what is the actual substrate and product of the WWOX enzyme activity? It is likely that understanding the normal role of WWOX and its relationship to chromosomal fragility are necessary in order to understand how the perturbation of these normal roles results in disease.

Entities:  

Keywords:  FRA16D; common chromosomal fragile sites; evolutionary conservation; intragenic homozygous deletion; megabase gene; oxido-reductase specificity

Year:  2021        PMID: 34210081     DOI: 10.3390/cells10071637

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  61 in total

1.  Introns in UTRs: why we should stop ignoring them.

Authors:  Alicia A Bicknell; Can Cenik; Hon N Chua; Frederick P Roth; Melissa J Moore
Journal:  Bioessays       Date:  2012-10-26       Impact factor: 4.345

2.  Chromosomal fragile site FRA16D and DNA instability in cancer.

Authors:  M Mangelsdorf; K Ried; E Woollatt; S Dayan; H Eyre; M Finnis; L Hobson; J Nancarrow; D Venter; E Baker; R I Richards
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

3.  A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.

Authors:  A J Paige; K J Taylor; A Stewart; J G Sgouros; H Gabra; G C Sellar; J F Smyth; D J Porteous; J E Watson
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

4.  Fragile sites and cancer breakpoints--the pessimistic view.

Authors:  G R Sutherland
Journal:  Cancer Genet Cytogenet       Date:  1988-03

5.  The FHIT gene 3p14.2 is abnormal in lung cancer.

Authors:  G Sozzi; M L Veronese; M Negrini; R Baffa; M G Cotticelli; H Inoue; S Tornielli; S Pilotti; L De Gregorio; U Pastorino; M A Pierotti; M Ohta; K Huebner; C M Croce
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

6.  Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.

Authors:  A Latil; O Cussenot; G Fournier; K Driouch; R Lidereau
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

7.  WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation.

Authors:  Cyril Mignot; Laetitia Lambert; Laurent Pasquier; Thierry Bienvenu; Andrée Delahaye-Duriez; Boris Keren; Jérémie Lefranc; Aline Saunier; Lila Allou; Virginie Roth; Mylène Valduga; Aissa Moustaïne; Stéphane Auvin; Catherine Barrey; Sandra Chantot-Bastaraud; Nicolas Lebrun; Marie-Laure Moutard; Marie-Christine Nougues; Anne-Isabelle Vermersch; Bénédicte Héron; Eva Pipiras; Delphine Héron; Laurence Olivier-Faivre; Jean-Louis Guéant; Philippe Jonveaux; Christophe Philippe
Journal:  J Med Genet       Date:  2014-11-19       Impact factor: 6.318

Review 8.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14

9.  Common chromosomal fragile site FRA16D tumor suppressor WWOX gene expression and metabolic reprograming in cells.

Authors:  Sonia Dayan; Louise V O'Keefe; Amanda Choo; Robert I Richards
Journal:  Genes Chromosomes Cancer       Date:  2013-06-13       Impact factor: 5.006

10.  Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data.

Authors:  Ramachandran S Vasan; Nicole L Glazer; Janine F Felix; Wolfgang Lieb; Philipp S Wild; Stephan B Felix; Norbert Watzinger; Martin G Larson; Nicholas L Smith; Abbas Dehghan; Anika Grosshennig; Arne Schillert; Alexander Teumer; Reinhold Schmidt; Sekar Kathiresan; Thomas Lumley; Yurii S Aulchenko; Inke R König; Tanja Zeller; Georg Homuth; Maksim Struchalin; Jayashri Aragam; Joshua C Bis; Fernando Rivadeneira; Jeanette Erdmann; Renate B Schnabel; Marcus Dörr; Robert Zweiker; Lars Lind; Richard J Rodeheffer; Karin Halina Greiser; Daniel Levy; Talin Haritunians; Jaap W Deckers; Jan Stritzke; Karl J Lackner; Uwe Völker; Erik Ingelsson; Iftikhar Kullo; Johannes Haerting; Christopher J O'Donnell; Susan R Heckbert; Bruno H Stricker; Andreas Ziegler; Thorsten Reffelmann; Margaret M Redfield; Karl Werdan; Gary F Mitchell; Kenneth Rice; Donna K Arnett; Albert Hofman; John S Gottdiener; Andre G Uitterlinden; Thomas Meitinger; Maria Blettner; Nele Friedrich; Thomas J Wang; Bruce M Psaty; Cornelia M van Duijn; H-Erich Wichmann; Thomas F Munzel; Heyo K Kroemer; Emelia J Benjamin; Jerome I Rotter; Jacqueline C Witteman; Heribert Schunkert; Helena Schmidt; Henry Völzke; Stefan Blankenberg
Journal:  JAMA       Date:  2009-07-08       Impact factor: 56.272

View more
  2 in total

Review 1.  WWOX-Related Neurodevelopmental Disorders: Models and Future Perspectives.

Authors:  Daniel J Steinberg; Rami I Aqeilan
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

2.  Effect of WW Domain-Containing Oxidoreductase Gene Polymorphism on Clinicopathological Characteristics of Patients with EGFR Mutant Lung Adenocarcinoma in Taiwan.

Authors:  Ju-Pi Li; Jinghua Tsai Chang; Po-Chung Ju; Ming-Hong Hsieh; Yu-Hua Chao; Thomas Chang-Yao Tsao; Ming-Ju Hsieh; Shun-Fa Yang
Journal:  Int J Environ Res Public Health       Date:  2021-12-13       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.